Form 4: Oncotelic Therapeutics Executive Receives Stock Grant
Insider Transaction (Form 4)
Saran Saund, CBO of Oncotelic Therapeutics, Inc., received 1,500 shares of common stock on July 10, 2026.
Summary
- Grant/award: acquired 1,500 Restricted stock Units on July 10, 2026; holds 1,500 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Saran Saund — Officer (CBO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-10 | Grant/award | Restricted stock Units | 1,500 | — | — | 1,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-10 | Grant/award (1,500 shares) |
Keywords
insider transaction, Form 4, OTLC, Oncotelic Therapeutics, Inc., neutral, Saran Saund
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.